Edition:
United States

AzurRx BioPharma Inc (AZRX.OQ)

AZRX.OQ on NASDAQ Stock Exchange Capital Market

2.64USD
19 Oct 2018
Change (% chg)

$-0.03 (-1.12%)
Prev Close
$2.67
Open
$2.63
Day's High
$2.71
Day's Low
$2.60
Volume
19,504
Avg. Vol
17,065
52-wk High
$4.08
52-wk Low
$2.19

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.216
Mar '18 0.00 -0.292
FY 2017 Dec '17 0.00 -0.215
Sep '17 0.00 -0.279
Jun '17 0.00 -0.265
Mar '17 0.00 -0.292
FY 2016 Dec '16 0.00 -0.608
Sep '16 0.00 -0.530
Jun '16 0.00 -0.392
Mar '16 0.00 -0.207
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 1 0.00 0.00 0.00 --
Year Ending Dec-18 1 0.00 0.00 0.00 0.00
Year Ending Dec-19 1 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Dec-18 1 -0.21 -0.21 -0.21 -0.17
Quarter Ending Mar-19 1 -0.20 -0.20 -0.20 --
Year Ending Dec-18 1 -0.91 -0.91 -0.91 -0.67
Year Ending Dec-19 1 -0.72 -0.72 -0.72 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 29.75 32.14
P/E High - Last 5 Yrs. -- 41.76 46.82
P/E Low - Last 5 Yrs. -- 23.56 24.71
Beta -- 0.89 0.87
Price to Sales (TTM) -- 4.59 6.55
Price to Book (MRQ) 5.24 3.64 4.00
Price to Tangible Book (MRQ) 8.54 5.22 6.10
Price to Cash Flow (TTM) -- 20.18 21.51
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 1.82 1.68
Dividend Yield - 5 Year Avg -- 1.53 1.45
Dividend 5 Year Growth Rate -- -8.81 -5.91
Payout Ratio(TTM) -- 49.52 46.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 5.48 7.91
Sales (TTM) vs TTM 1 Yr. Ago -- 4.52 6.56
Sales - 5 Yr. Growth Rate -- 6.86 7.49
EPS (MRQ) vs Qtr. 1 Yr. Ago 18.53 19.36 26.63
EPS (TTM) vs TTM 1 Yr. Ago 40.94 -- --
EPS - 5 Yr. Growth Rate -- 6.47 7.65
Capital Spending - 5 Yr. Growth Rate -- 7.62 8.16

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.22 2.22
Current Ratio (MRQ) 3.31 2.97 2.99
LT Debt to Equity (MRQ) 0.00 8.83 11.31
Total Debt to Equity (MRQ) 3.70 11.15 14.15
Interest Coverage (TTM) -1.65 40.44 34.46

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.18 54.36
Gross Margin - 5 Yr. Avg. -- 53.20 53.16
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.67 16.13
Operating Margin (TTM) -- 12.80 3.36
Operating Margin - 5 Yr. Avg. -- 14.30 11.28
Pre-Tax Margin (TTM) -- 13.31 3.79
Pre-Tax Margin - 5 Yr. Avg. -- 14.69 11.54
Net Profit Margin (TTM) -- 9.92 0.60
Net Profit Margin - 5 Yr. Avg. -- 10.95 7.83
Effective Tax Rate (TTM) -- 20.78 20.73
Effective Tax Rate - 5 Yr. Avg. -- 23.93 24.38

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 833,339,537 725,680,242
Net Income/Employee (TTM) -- 96,510,060 84,001,075
Receivable Turnover (TTM) -- 5.04 5.06
Inventory Turnover (TTM) -- 2.55 3.65
Asset Turnover (TTM) 0.00 0.84 0.82

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -122.49 10.12 9.83
Return on Assets - 5 Yr. Avg. -- 11.43 10.94
Return on Investment (TTM) -163.80 13.18 12.83
Return on Investment - 5 Yr. Avg. -- 14.72 14.05
Return on Equity (TTM) -204.64 15.14 14.95
Return on Equity - 5 Yr. Avg. -- 15.90 15.39
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 53.46 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for AzurRx BioPharma Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 18.64%
# of Holders: 20
Total Shares Held: 3,152,907
3 Mo. Net Change: -523
# New Positions: 0
# Closed Positions: 1
# Increased Positions: 0
# Reduced Positions: 2
# Net Buyers: -2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.